NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells
Briefly

Our research uncovered a previously unknown mechanism that plays an important role in NK cell memory against glioblastoma, highlighting the potential of NK cells engineered to express IL-21 in treating this disease.
The ability of these IL-21 engineered natural killer cells to recognize and kill glioblastoma stem cell-like cells offers a highly promising therapeutic approach.
Read at ScienceDaily
[
]
[
|
]